Koczywas, Marianna

A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non–small cell lung cancer after failure of prior chemotherapy and erlotinib

Reckamp, K. L., Giaccone, G., Camidge, D. R., Gadgeel, S. M., Khuri, F. R., Engelman, J. A., Koczywas, M., Rajan, A., Campbell, A. K., Gernhardt, D., et al. (2014) · Cancer

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 144

Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer

Mohanty, A., Nam, A., Srivastava, S., Jones, J., Lomenick, B., Singhal, S. S., Guo, L., Cho, H., Li, A., Behal, A., et al. (2023) · Science Advances

Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling

Cited by 79

A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical Trial

Ou, S. I., Koczywas, M., Ulahannan, S., Janne, P., Pacheco, J., Burris, H., McCoach, C., Wang, J. S., Gordon, M., Haura, E., et al. (2020) · Journal of Thoracic Oncology

Protein Tyrosine PhosphatasesLung Cancer Treatments and Mutations

Cited by 73

Understanding Caregiver Quality of Life in Caregivers of Hospitalized Older Adults with Cancer

Hsu, T., Nathwani, N., Loscalzo, M., Chung, V., Chao, J., Karanes, C., Koczywas, M., Forman, S., Lim, D., Siddiqi, T., et al. (2019) · Journal of the American Geriatrics Society

Nursing care and researchCancer survivorship and care

Cited by 60

Phase 2, multicenter study of the EZH2 inhibitor tazemetostat as monotherapy in adults with relapsed or refractory (R/R) malignant mesothelioma (MM) with BAP1 inactivation.

Zauderer, M. G., Szlosarek, P., Le Moulec, S., Popat, S., Taylor, P., Planchard, D., Scherpereel, A., Jahan, T., Koczywas, M., Forster, M., et al. (2018) · Journal of Clinical Oncology

Occupational and environmental lung diseasesIntraperitoneal and Appendiceal Malignancies

Cited by 54

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER

Goldman, J. W., Mazieres, J., Barlesi, F., Dragnev, K. H., Koczywas, M., Göskel, T., Cortot, A. B., Girard, N., Wesseler, C., Bischoff, H., et al. (2020) · Frontiers in Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 52

The impact of lung cancer surgery on quality of life trajectories in patients and family caregivers

Kim, J. Y., Sun, V., Raz, D. J., Williams, A. C., Fujinami, R., Reckamp, K., Koczywas, M., Cristea, M., Hurria, A., & Ferrell, B. (2016) · Lung Cancer

Cancer survivorship and careNursing care and research

Cited by 48

A nurse-led intervention for fear of cancer progression in advanced cancer: A pilot feasibility study

Reb, A. M., Borneman, T., Economou, D., Cangin, M. A., Cope, D. G., Ma, H., Ruel, N., Sharpe, L., Patel, S. K., Cristea, M., et al. (2020) · European Journal of Oncology Nursing

Cancer survivorship and carePalliative and Oncologic Care

Cited by 26

Phase I study of TRC102 in combination with cisplatin and pemetrexed in patients with advanced solid tumors/Phase II study of TRC102 with pemetrexed in patients with mesothelioma refractory to pemetrexed and cisplatin or carboplatin.

Koczywas, M., Frankel, P. H., Riess, J. W., El-Khoueiry, A. B., Villaruz, L. C., Leong, S., Ruel, C., Synold, T. W., O'Connor, T., & Newman, E. M. (2020) · Journal of Clinical Oncology

Occupational and environmental lung diseasesCancer therapeutics and mechanisms

Cited by 2